ANTIBIOTIC RESISTANCE: A PHARMACEUTICAL PERSPECTIVE

Antibiotic resistance has become one of the most serious threats to global public health, significantly limiting the effectiveness of antimicrobial therapy. The increasing prevalence of multidrug-resistant bacteria has created major challenges for pharmaceutical research, clinical practice, and healthcare systems worldwide. This article aims to analyze antibiotic resistance from a pharmaceutical perspective, focusing on its causes, clinical implications, and strategies for prevention and control.

A systematic review of international scientific literature published between 2015 and 2025 was conducted using major academic databases. The findings indicate that irrational antibiotic use, inadequate regulatory control, and the slow development of new antimicrobial agents are the primary factors contributing to resistance. The results also demonstrate that pharmaceutical interventions, including antimicrobial stewardship programs, rational prescribing, dosage optimization, and patient education, play a crucial role in reducing resistance development.

Furthermore, the study highlights the growing importance of innovative pharmaceutical approaches such as drug repurposing, combination therapy, and artificial intelligence–based drug discovery. These strategies offer promising solutions for improving antibiotic effectiveness and supporting sustainable antimicrobial therapy.

In conclusion, antibiotic resistance requires a comprehensive pharmaceutical response that integrates scientific innovation, professional pharmaceutical care, and interdisciplinary collaboration to ensure effective infection management and long-term public health protection.

抗生素耐药性已成为全球公共卫生面临的最严峻威胁之一，大幅削弱了抗菌治疗的临床有效性。多重耐药菌感染率的持续攀升，给全球范围内的药学研究、临床实践与医疗健康系统均带来了严峻挑战。本研究旨在从药学视角剖析抗生素耐药性问题，重点探讨其成因、临床影响及防控策略。

本研究依托主流学术数据库，对2015年至2025年间发表的国际科学文献开展了系统综述。研究结果显示，抗生素不合理使用、监管管控不足以及新型抗菌药物研发滞后，是导致耐药性产生的核心因素。研究同时证实，药学干预手段——包括抗菌药物管理计划（Antimicrobial Stewardship Programs）、合理处方、剂量优化以及患者教育——在延缓耐药性发展进程中发挥着关键作用。

此外，本研究着重指出，药物重定位、联合治疗以及基于人工智能的药物研发等创新药学手段的重要性日益凸显。此类策略为提升抗生素临床效力、保障抗菌治疗的可持续性提供了极具前景的解决方案。

综上，抗生素耐药性问题需要依托整合科学创新、专业药学服务与跨学科协作的综合性药学应对方案，以确保感染管理的有效性，并实现公共卫生的长期保护。